This page brings together the Agency's latest information on HIV and AIDS.
the ten newest and recently updated medicines authorised for the treatment of HIV and AIDS in the European Union (EU);
the most recent opinions on medicines against HIV and AIDS that are pending authorisation by the European Commission (EC);
the latest HIV- and AIDS-related news and press releases;
the Agency's events on HIV- and AIDS-related topics.
New and recently updated medicines
Opinions pending EC decision
EMA recommends removal of class warnings for several medicines ... Read more
EMA supports World AIDS Day on 1 December ... Read more
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 September 2014
Fifteen new medicines and three extensions of indication recommended for approval ... Read more
This page provides an overview of the opinions adopted at the June 2014 meeting of the Committee for Medicinal Products for Human Use (CHMP) and other important outcomes. ... Read more
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorisation for Tivicay in combination with other antiretroviral medicines for the treatment of adults and adolescents over 12 years of age infected with human immunodeficiency virus (HIV). ... Read more
Expert meeting on paediatric development of fixed-dose combinations for the treatment of the human immunodeficiency virus (HIV)
As a requirement of the Paediatric Regulation, all new medicinal products developed for the treatment of HIV-1 infection in adults, must have an agreed paediatric investigation plan (PIP) in place, ensuring the necessary data are obtained to support the medicine's authorisation for use in children, when appropriate. The Paediatric Committee (PDCO) is responsible for agreeing these PIPs. The purpose of this expert meeting is to advise the EMA and the PDCO on the best development pathways for fixed-dose combinations for the treatment of children and adolescents living with HIV. ... Read more
The paediatric HIV expert group meeting is being held to identify the best possible development approaches for existing and new medicines in the field of HIV in childhood and adolescence for paediatric investigation plans. ... Read more